Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Market Cap : NT$1,886.24 Mil (As of Jun. 11, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Great Novel Therapeutics Biotech & Medicals's share price for the quarter that ended in Dec. 2023 was NT$64.2535. Great Novel Therapeutics Biotech & Medicals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 39.88 Mil. Therefore, Great Novel Therapeutics Biotech & Medicals's market cap for the quarter that ended in Dec. 2023 was NT$2,562.31 Mil.

Great Novel Therapeutics Biotech & Medicals's quarterly market cap increased from Dec. 2022 (NT$1,824.58 Mil) to Jun. 2023 (NT$3,781.02 Mil) but then declined from Jun. 2023 (NT$3,781.02 Mil) to Dec. 2023 (NT$2,562.31 Mil).

Great Novel Therapeutics Biotech & Medicals's annual market cap increased from Dec. 2021 (NT$930.09 Mil) to Dec. 2022 (NT$1,824.58 Mil) and increased from Dec. 2022 (NT$1,824.58 Mil) to Dec. 2023 (NT$2,562.31 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Great Novel Therapeutics Biotech & Medicals's Enterprise Value for Today is NT$1,424.06 Mil.

Great Novel Therapeutics Biotech & Medicals Market Cap Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals Market Cap Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

930.09

1,824.58

2,562.31

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial					930.09	770.93	1,824.58	3,781.02	2,562.31

Competitive Comparison of Great Novel Therapeutics Biotech & Medicals's Market Cap

For the Biotechnology subindustry, Great Novel Therapeutics Biotech & Medicals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Novel Therapeutics Biotech & Medicals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Great Novel Therapeutics Biotech & Medicals's Market Cap distribution charts can be found below:

* The bar in red indicates where Great Novel Therapeutics Biotech & Medicals's Market Cap falls into.

Great Novel Therapeutics Biotech & Medicals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Great Novel Therapeutics Biotech & Medicals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	NT$64.2535	*	39.8782
	=	NT$2,562.31

Great Novel Therapeutics Biotech & Medicals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	NT$64.2535	*	39.8782
	=	NT$2,562.31

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Great Novel Therapeutics Biotech & Medicals Market Cap Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines